ARTICLE SUMMARY 4
Thearticle titled U.SHealthcare Reform and the Pharmaceutical Industryis written by Arthur Daemmrich. The author talks about the patientprotection and affordable care act of 2010. The article describes notonly the institutional but also the political context whereby the actwas passed, how it was developed, and its effects on thebiopharmaceutical sector. The article evaluates how the act is likelyto impact the biopharmaceutical sector, as well as examining thecompetitive dynamics that exists within the industry.
Thefirst part of the article provides background information about thereforms, hence giving the readers insight on what it involves. Theauthor starts by giving history of the act and the provisionsassociated with it, how the act functions, and the population that isentitled to benefit from it. In other words, the introduction partprepares the readers on what they should expect.
Daemmrich(2011) develops his point using information from the congressionaldebate, public demonstrations, and lobbying from the insurers anaspect that makes the information provided to be credible. The authorfurther talks of how the reform would reduce the spending in thesector, and how it is of historical significance to the industry.
Consequently,the author uses statistics and facts that make the providedinformation to be credible. For example, there is information on thetotal expenditure on the healthcare spending whereby Americangovernment used 60% of its income on patient care and insurance. Inproviding information on the number of patients that die annually,lack of insurance remains one of the contributing factors.
Theauthor further develops the paper using two ambitions. The first oneis how the reform contributed to healthcare political economy.Daemmrich (2011) develops the point by drawing research from the U.Shealthcare system. He further achieves the same using the politicalbarriers associated with universal coverage. Using a historicalinstitutionalist analysis, the author makes the readers to have aclear understanding of how the healthcare reform was a major policyagenda between 2009 and 2010.
Additionally,the author discusses the history of healthcare reforms in the U.S anaspect that differentiates the reform from other existing ones.Through history, one can relate how easily the reform can help theAmericans enjoy reduced costs in the healthcare sector. The articleis divided using sub-topics making it easier to filter information.Use of graphs and charts makes the information compact, thusenhancing comparison. The topics are well developed and support theargument of the author. Additionally, the language used is simple anaspect that enhances readability (Daemmrich, 2011). Lastly, theauthor ensures that there is logical flow of information.
Moreover,the article is a good read on the healthcare reforms, and it enhancesthe nursing sector as it makes the healthcare affordable for allAmericans. Furthermore, the nursing sector have benefitted from thereforms both directly and indirectly. For example, the state hasabsorbed more nurses into the state-owned health facilities.
Inconclusion, despite the strengths, the article also has itsweaknesses. First, the author does not explain some of the technicalterms used in the article. The author could have made the articlemore compact by using fewer words to pass the message across.Additionally, more previous studies and information frominternational bodies such as U.N could have been used to make theinformation more credible.
Daemmrich,A. (2011). U.Shealthcare reform and the pharmaceutical industry.Boston:Harvard Business School.